Related references
Note: Only part of the references are listed.The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma
Vignesh Raman et al.
ANNALS OF SURGERY (2022)
Association between age and disease specific mortality in medullary thyroid cancer
Zeyad T. Sahli et al.
AMERICAN JOURNAL OF SURGERY (2021)
Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery
Jiajia Tang et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency
Sara Milicevic et al.
CROATIAN MEDICAL JOURNAL (2021)
Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
Hyunju Park et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies
Tiffany Yeh et al.
THYROID (2020)
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study
Tal Rozenblat et al.
EJSO (2020)
Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
Li Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis
Jinluan Li et al.
ESMO OPEN (2020)
Management of Medullary Thyroid Cancer
David Viola et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)
Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma A population-based study using the SEER 18 database
Kexin Meng et al.
MEDICINE (2019)
Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study
Jes Sloth Mathiesen et al.
ENDOCRINE CONNECTIONS (2018)
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
So Young Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach
Weiye Deng et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years
Reese W. Randle et al.
SURGERY (2017)
Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer
Anisley Valenciaga et al.
THYROID (2017)
Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression
Viviana Anelli et al.
eLife (2017)
Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer
Mohamed Abdelgadir Adam et al.
JAMA SURGERY (2017)
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
M. Schlumberger et al.
ANNALS OF ONCOLOGY (2017)
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma
Yingjie Shao et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis
Ning Qu et al.
ONCOTARGET (2016)
Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis
Felice Giuliante et al.
JAMA SURGERY (2016)
Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis
Donald S. A. McLeod et al.
THYROID (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Guidelines for the management of thyroid cancer
Petros Perros et al.
CLINICAL ENDOCRINOLOGY (2014)
The Effect of Extent of Surgery and Number of Lymph Node Metastases on Overall Survival in Patients with Medullary Thyroid Cancer
Nazanene H. Esfandiari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Conditional Survival in Patients with Thyroid Cancer
Mousumi Banerjee et al.
THYROID (2014)
Prognostic Impact of N Staging in 715 Medullary Thyroid Cancer Patients Proposal for a Revised Staging System
Andreas Machens et al.
ANNALS OF SURGERY (2013)
Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare Data
Jennifer M. Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer
Andreas Machens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Sporadic and Familial Medullary Thyroid Carcinoma: State of the Art
Tricia A. Moo-Young et al.
SURGICAL CLINICS OF NORTH AMERICA (2009)
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression - A multivariate analysis
Andreas Machens et al.
ARCHIVES OF SURGERY (2007)
Share Paper
